Meta-analysis of Blood Pressure and the CYP11B2 Polymorphism Highlights the Need for Better Designed Studies.

Jan A Staessen,Yan Li,Lutgarde Thijs

DOI: https://doi.org/10.1097/hjh.0b013e32801143b3

IF: 4.9

2007-01-01

Journal of Hypertension

Abstract:The distribution of blood pressure in populations is almost certainly dependent on a mosaic of many genetic loci each with a minute contribution and is under the influence of multiple gene–gene [1] and gene–environment [2] interactions. Unravelling the genetic determinants of hypertension mainly rests on three approaches. First, whole-genome scans search for linkage peaks with traits of interest, and in the case of positive linkage, lead to further experimental and clinical studies to characterize potential loci of interest. Second, high-throughput genotyping using modern chip technology is like casting a net in a pond containing plenty of fish with the hope that subsequent sorting will identify the goldfish (i.e. the rare polymorphic markers carrying the breakthrough information). Finally, the candidate gene approach builds on existing pathophysiological knowledge and common polymorphisms in genes known to be involved in some aspects of blood pressure regulation. Usually, a few seminal studies raise the interest in a particular, preferably functional, polymorphism in a candidate gene. Next, large-scale case– control designs or association studies in patient cohorts or in the population at large attempt to reproduce the initial observations, but rarely generate consistent findings [3]. This is not surprising because, as outlined elsewhere [4,5], methodological issues limit the interpretation of many published studies. Key obstacles are the lack of standardization, the arbitrary dichotomization of continuous phenotypes, the inappropriate selection of cases and controls, population admixture and stratification, an insufficient sample size, and a failure to account for confounders or environmental factors. Quantitative systematic reviews, commonly known as meta-analyses, offer the possibility to provide pooled estimates across a large number of studies on a given cardiovascular trait in relation to a genetic polymorphism and to identify sources of heterogeneity in the published results.